This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.
Stocks · News reference
Pediatrix Medical Group shares are trading higher after the company provided an update on its second quarter 2026 business trends.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.
Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call
Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to